organization · Reporting owner
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CONTRAFECT Corp
Report date December 04, 2018 · Filed December 06, 2018
Section 16 reporting ended · disclosed 2018-12-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Indirectby Fosun Industrial Co., Limited | 7,900,000 |
Reported balance
After 2018-12-04 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2018-12-04 · Sale · Disposed 600,000 · Balance 7,900,000 F1: Fosun Industrial Co., Limited is a wholly owned subsidiary of the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Fosun Industrial Co., Limited is a wholly owned subsidiary of the Reporting Person.
NATURES SUNSHINE PRODUCTS INC
Report date June 27, 2025 · Filed June 27, 2025
Jointly reported with Fosun Pharma USA Inc.
Section 16 reporting ended · disclosed 2025-06-27. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Indirectby Fosun Pharma USA Inc. | 0 |
Reported balance
After 2025-06-27 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-06-27 · Sale · Disposed 2,854,607 · Balance 0 F1: The shares were sold pursuant to that certain Underwriting Agreement. dated June 25, 2025, among Fosun Pharma USA Inc., the Issuer, and the underwriter party thereto. F2: Fosun Pharma USA Inc. is a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. |
| Common StockSEC Table I · non-derivative | Indirectby Fosun Industrial Co., Limited | 64,167 |
Reported balance
Holding disclosure · report date 2025-06-27 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 64,167 F3: Fosun Industrial Co., Limited is a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were sold pursuant to that certain Underwriting Agreement. dated June 25, 2025, among Fosun Pharma USA Inc., the Issuer, and the underwriter party thereto.
F2: Fosun Pharma USA Inc. is a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
F3: Fosun Industrial Co., Limited is a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 27, 2025 Filed Jun 27, 2025 20:27 UTC | NATURES SUNSHINE PRODUCTS INC NATR · Entity 1465 | SaleCommon Stock | 2,854,607 | $11.46 | $32,713,796.22 |
DisclosureSEC source: 0001140361-25-023976 · form4.xml · nonDerivative · entry 1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. · CIK 0001615258 · 10% owner Fosun Pharma USA Inc. · CIK 0002071437 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · by Fosun Pharma USA Inc. Disclosed balance after: 0 F1 · kind: The shares were sold pursuant to that certain Underwriting Agreement. dated June 25, 2025, among Fosun Pharma USA Inc., the Issuer, and the underwriter party thereto. F2 · ownership.nature: Fosun Pharma USA Inc. is a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 10:00 UTC | NATURES SUNSHINE PRODUCTS INC NATR · Entity 1465 | SaleCommon Stock | 2,300 | $13.02 | $29,946.00 |
DisclosureSEC source: 0001104659-24-109317 · tm2426270-1_4seq1.xml · nonDerivative · entry 1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. · CIK 0001615258 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · by Fosun Industrial Co., Limited Disclosed balance after: 64,167 F1 · ownership.nature: Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person. Read SEC document |
| October 14, 2024 Filed Oct 15, 2024 12:48 UTC | NATURES SUNSHINE PRODUCTS INC NATR · Entity 1465 | SaleCommon Stock | 1,300 | $13.12 | $17,056.00 |
DisclosureSEC source: 0001104659-24-108390 · tm2426189-1_4seq1.xml · nonDerivative · entry 7 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. · CIK 0001615258 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · by Fosun Industrial Co., Limited Disclosed balance after: 66,467 F2 · ownership.nature: Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 12:48 UTC | NATURES SUNSHINE PRODUCTS INC NATR · Entity 1465 | SaleCommon Stock | 1,580 | $13.37 | $21,124.60 |
DisclosureSEC source: 0001104659-24-108390 · tm2426189-1_4seq1.xml · nonDerivative · entry 6 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. · CIK 0001615258 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · by Fosun Industrial Co., Limited Disclosed balance after: 67,767 F2 · ownership.nature: Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person. Read SEC document |
| October 10, 2024 Filed Oct 15, 2024 12:48 UTC | NATURES SUNSHINE PRODUCTS INC NATR · Entity 1465 | SaleCommon Stock | 3,000 | $13.39 | $40,170.00 |
DisclosureSEC source: 0001104659-24-108390 · tm2426189-1_4seq1.xml · nonDerivative · entry 5 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. · CIK 0001615258 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · by Fosun Industrial Co., Limited Disclosed balance after: 69,347 F2 · ownership.nature: Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person. Read SEC document |
| October 09, 2024 Filed Oct 15, 2024 12:48 UTC | NATURES SUNSHINE PRODUCTS INC NATR · Entity 1465 | SaleCommon Stock | 1,816 | $13.36 | $24,261.76 |
DisclosureSEC source: 0001104659-24-108390 · tm2426189-1_4seq1.xml · nonDerivative · entry 4 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. · CIK 0001615258 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · by Fosun Industrial Co., Limited Disclosed balance after: 72,347 F2 · ownership.nature: Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person. Read SEC document |
| October 08, 2024 Filed Oct 15, 2024 12:48 UTC | NATURES SUNSHINE PRODUCTS INC NATR · Entity 1465 | SaleCommon Stock | 1,800 | $13.13 | $23,634.00 |
DisclosureSEC source: 0001104659-24-108390 · tm2426189-1_4seq1.xml · nonDerivative · entry 3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. · CIK 0001615258 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · by Fosun Industrial Co., Limited Disclosed balance after: 74,163 F2 · ownership.nature: Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person. Read SEC document |
| October 01, 2024 Filed Oct 15, 2024 12:48 UTC | NATURES SUNSHINE PRODUCTS INC NATR · Entity 1465 | SaleCommon Stock | 1,399 | $13.54 | $18,942.46 |
DisclosureSEC source: 0001104659-24-108390 · tm2426189-1_4seq1.xml · nonDerivative · entry 2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. · CIK 0001615258 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · by Fosun Industrial Co., Limited Disclosed balance after: 75,963 F2 · ownership.nature: Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person. Read SEC document |
| September 06, 2024 Filed Oct 15, 2024 12:48 UTC | NATURES SUNSHINE PRODUCTS INC NATR · Entity 1465 | OtherCommon Stock | 2,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-108390 · tm2426189-1_4seq1.xml · nonDerivative · entry 1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. · CIK 0001615258 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · by Fosun Industrial Co., Limited Disclosed balance after: 77,362 F1 · shares: These shares represent shares that were issued to Fosun Industrial Co., Limited upon the delivery of certain vested restricted stock units that were initially granted to a former director of the Issuer (the "Former Director"), as agreed between the Former Director and the Reporting Person. F2 · ownership.nature: Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person. Read SEC document |
| January 21, 2022 Filed Jan 24, 2022 14:56 UTC | NATURES SUNSHINE PRODUCTS INC NATR · Entity 1465 | OtherCommon Stock | 25,000 | $8.72 | $218,000.00 |
DisclosureSEC source: 0001104659-22-006711 · tm224261-1_4seq1.xml · nonDerivative · entry 3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. · CIK 0001615258 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Fosun Industrial Co., Limited Disclosed balance after: 74,394 F4 · shares: These shares represent shares that were issued to Fosun Industrial Co., Limited on the instruction of the Former Director upon the exercise of certain stock options (the "Options") that were initially granted to the Former Director, as agreed between the Former Director and the Reporting Person. F5 · price: Represents the exercise price paid by Fosun Industrial Co., Limited for the shares underlying the Options upon the exercise of the Options. F2 · ownership.nature: Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person. Read SEC document |
| January 07, 2022 Filed Jan 24, 2022 14:56 UTC | NATURES SUNSHINE PRODUCTS INC NATR · Entity 1465 | OtherCommon Stock | 9,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-006711 · tm224261-1_4seq1.xml · nonDerivative · entry 2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. · CIK 0001615258 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Fosun Industrial Co., Limited Disclosed balance after: 49,394 F3 · shares: These shares represent shares that were issued to Fosun Industrial Co., Limited on the instruction of the Former Director upon the delivery of certain vested restricted stock units that were initially granted to the Former Director, as agreed between the Former Director and the Reporting Person. F2 · ownership.nature: Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person. Read SEC document |
| April 12, 2021 Filed Jan 24, 2022 14:56 UTC | NATURES SUNSHINE PRODUCTS INC NATR · Entity 1465 | OtherCommon Stock | 711 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-006711 · tm224261-1_4seq1.xml · nonDerivative · entry 1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. · CIK 0001615258 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Fosun Industrial Co., Limited Disclosed balance after: 39,836 F1 · shares: These shares represent incremental shares granted by the Issuer as an adjustment to the vested option award of a former director of the Issuer (the "Former Director"). These shares initially reported on a Form 4 filed by the Former Director, but were actually issued to Fosun Industrial Co., Limited. Due to this oversight, a Form 4 was not previously filed by the Reporting Person regarding this issuance. F2 · ownership.nature: Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 11:10 UTC | NATURES SUNSHINE PRODUCTS INC NATR · Entity 1465 | OtherCommon Stock, no par value per share | 25,000 | $7.80 | $195,000.00 |
DisclosureSEC source: 0001104659-19-072359 · tm1925169-1_4.xml · nonDerivative · entry 2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. · CIK 0001615258 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Fosun Industrial Co., Limited Disclosed balance after: 39,125 F3 · shares: These shares represent shares that were issued to Fosun Industrial Co., Limited on the instruction of a former director of the Issuer upon the exercise of certain stock options (the "Options") that were initially granted to the former director, as agreed between the former director and the Reporting Person. F4 · price: Represents the exercise price paid by Fosun Industrial Co., Limited on behalf of the former director of the Issuer for the shares underlying the Options upon the exercise of the Options. F2 · ownership.nature: Fosun Industrial Co., Limited is a wholly owned subsidiary of the Reporting Person. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 11:10 UTC | NATURES SUNSHINE PRODUCTS INC NATR · Entity 1465 | OtherCommon Stock, no par value per share | 14,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-072359 · tm1925169-1_4.xml · nonDerivative · entry 1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. · CIK 0001615258 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Fosun Industrial Co., Limited Disclosed balance after: 14,125 F1 · shares: These shares represent shares that were issued to Fosun Industrial Co., Limited on the instruction of a former director of the Issuer upon the vesting of certain restricted stock units that were initially granted to the former director, as agreed between the former director and the Reporting Person. F2 · ownership.nature: Fosun Industrial Co., Limited is a wholly owned subsidiary of the Reporting Person. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 16:51 UTC | CONTRAFECT Corp CFRX · Entity 116797 | SaleCommon Stock | 600,000 | $2.04 | $1,224,000.00 |
DisclosureSEC source: 0001144204-18-063392 · tv508579_4.xml · nonDerivative · entry 1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. · CIK 0001615258 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Fosun Industrial Co., Limited Disclosed balance after: 7,900,000 F1 · ownership.nature: Fosun Industrial Co., Limited is a wholly owned subsidiary of the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.